Loading market dashboard
Axsome Therapeutics, Inc.
AXSMHealthcareNASDAQUS
Loading analysis workspace
Estimates, scoring, valuation assumptions, and peer comparison in one research surface.
Axsome Therapeutics, Inc. · Forecast overview
Bars show expected revenue while the line tracks expected EPS.
| Period | Revenue avg | Revenue range | EBITDA | EPS avg | Analysts |
|---|---|---|---|---|---|
| Dec 2030 | $3.76B | $3.14B - $4.45B | -$1.35B | $31.607 | 8 |
| Dec 2029 | $3.09B | $2.59B - $3.66B | -$1.11B | $24.68 | 14 |
| Dec 2028 | $2.28B | $2.28B - $2.28B | -$820.66M | $14.424 | 17 |
| Dec 2027 | $1.58B | $1.17B - $1.85B | -$568.77M | $5.523 | 16 |
| Dec 2026 | $983.80M | $865.90M - $1.12B | -$354.46M | -$1.962 | 16 |
| Dec 2025 | $635.67M | $624.89M - $638.92M | -$229.03M | -$3.758 | 15 |
| Dec 2024 | $385.05M | $380.45M - $387.80M | -$138.73M | -$5.456 | 11 |
| Dec 2023 | $291.49M | $244.02M - $345.78M | -$105.02M | -$6.514 | 9 |
| Dec 2022 | $46.98M | $42.96M - $50.74M | -$5.06M | -$4.333 | 3 |